SHELTON, CT / ACCESSWIRE / July 11, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader…
Sapiens' expanded offering maximizes business value for MPL insurers, supporting growth and retention ROCHELLE PARK, N.J., July 2, 2024…
Recommendation based on data from the Phase 1 and pivotal Phase 2 trials demonstrating robust and durable response rates in…
SEATTLE, June 20, 2024 /PRNewswire/ -- Even as the role of wildlife in disease outbreaks is increasingly recognized, our ability to…
REDWOOD CITY, Calif., June 19, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company…
Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of…
– Company also receives short extension of its credit agreement until July 31, 2024 –MINNEAPOLIS, June 17, 2024 (GLOBE NEWSWIRE)…
At 14-months median follow-up in the pivotal trial, 50% of patients achieved a complete response or better and a 71%…
LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today announces the UK and…
Company to share groundbreaking technology at the AgeTech Collaborative from AARP as part of their launch. BROOKLYN, N.Y., June 10,…